Summary of best response by blinded independent central review per Response Evaluation Criteria in Solid Tumors V.1.1
| Response evaluation* | No. patients (n=50) | % | 95% CI† |
| Complete response (CR) | 15 | 30 | 17.9 to 44.6 |
| Partial response (PR) | 14 | 28 | 16.2 to 42.5 |
| Objective response (CR+PR) | 29 | 58 | 43.2 to 71.8 |
| Stable disease (SD) | 4 | 8 | 2.2 to 19.2 |
| Disease control (CR+PR+SD) | 33 | 66 | 51.2 to 78.8 |
| Progressive disease | 16 | 32 | 19.5 to 46.7 |
| No assessment‡ | 1 | 2 | 0.1 to 10.6 |
*Only confirmed responses are included.
†Based on binomial exact CI method.
‡One subject had a baseline tumor assessment but could not be reassessed after starting therapy, due to illness and death before the first on-treatment scan.